It's no secret that developing a new drug or medical device is an expensive and time-consuming endeavor. Often, despite the best efforts of those involved, traditional clinical trials end up wasting ...
NORTHAMPTON, MA / ACCESS Newswire / February 11, 2026 / The Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards), along with the American Heart Association (Heart Association), and ...
Huntsman Cancer Institute at the University of Utah (the U) has joined other institutions in an innovative clinical trials program designed to match patients with acute myeloid leukemia (AML) and ...
STATEN ISLAND, N.Y., March 9, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for ...
NATIONAL — [March 31, 2026] — The Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards), an initiative dedicated to improving participation in and access to clinical trials, is ...
Clinical trials are frightening endeavors for biotech investors. Expensive and fraught with risk, a trial’s failure can seriously lighten an investor’s pockets with little hope of recourse. After ...
A new in-person program designed to prepare professionals for advanced roles in clinical research and data analysis is now open for enrollment. TORONTO, March 20, 2025 /CNW/ - Canada's healthcare ...
CEO Brian Lian highlighted the company's progress in advancing its VK2735 obesity program, with Phase 3 trials for the subcutaneous formulation set to begin later in Q2 2025. Additionally, enrollment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results